{
    "2021-04-16": [
        [
            {
                "time": "",
                "original_text": "国药集团据悉计划将新冠疫苗资产注入天坛生物",
                "features": {
                    "keywords": [
                        "国药集团",
                        "新冠疫苗",
                        "资产注入",
                        "天坛生物"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物回应注入疫苗资产：尚未接到相关通知",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "疫苗资产",
                        "回应",
                        "通知"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}